Format

Send to

Choose Destination
Leukemia. 2014 Feb;28(2):451-5. doi: 10.1038/leu.2013.298. Epub 2013 Oct 18.

The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients.

Author information

1
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
2
Tolero Pharmaceuticals Inc., Salt Lake City, UT, USA.
PMID:
24217154
PMCID:
PMC3929965
DOI:
10.1038/leu.2013.298
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center